MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA

Osteosarcoma has become one of the most common primary malignant bone tumors in childhood and adult. Numerous studies have demonstrated that aberrant microRNA (miRNA) expression is involved in human disease including cancer. To date, the potential miRNAs regulating osteosarcoma growth and progressio...

Full description

Saved in:
Bibliographic Details
Published in:Tumor biology 2015-11, Vol.36 (11), p.8579-8584
Main Authors: Shi, Zhi-cai, Chu, Xue-rong, Wu, Yun-gang, Wu, Jin-hui, Lu, Chun-wen, Lü, Run-xiao, Ding, Mu-chen, Mao, Ning-fang
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Bone cancer
Cancer Research
Cell growth
Cell Line, Tumor
Cell Proliferation - genetics
Cell Transformation, Neoplastic - genetics
Class I Phosphatidylinositol 3-Kinases
Gene Expression Regulation, Neoplastic
Genes, Tumor Suppressor
Humans
MicroRNAs
MicroRNAs - biosynthesis
MicroRNAs - genetics
Osteosarcoma - genetics
Osteosarcoma - pathology
Phosphatidylinositol 3-Kinases - biosynthesis
Phosphatidylinositol 3-Kinases - genetics
Research Article
Signal Transduction
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Osteosarcoma has become one of the most common primary malignant bone tumors in childhood and adult. Numerous studies have demonstrated that aberrant microRNA (miRNA) expression is involved in human disease including cancer. To date, the potential miRNAs regulating osteosarcoma growth and progression are not fully identified yet. Herein, we showed that miR-375 was frequently downregulated in osteosarcoma tissue and cell lines compared to normal human colon tissues. Overexpression of miR-375 resulted in decreased expression of PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) at both mRNA and protein levels. We found that miR-375 overexpression markedly suppressed cell proliferation in vitro. And inhibition of miR-375 promotes osteosarcoma growth. Mechanistic studies showed that PIK3CA was a potential target of miR-375 and it mediated reduction of PIK3CA resulted in suppression of PI3K/Akt pathway. Taken together, our results demonstrate that miR-375 functions as a growth-suppressive miRNA and plays an important role in inhibiting the tumorigenesis through targeting PIK3CA in osteosarcoma.
ISSN:1010-4283
1423-0380
DOI:10.1007/s13277-015-3614-9